RADIOTHER ONCOL 润色咨询

RADIOTHERAPY AND ONCOLOGY

出版年份:1983 年文章数:4073 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:19.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2021-09-21 1dd96cb3m86(暂无匿称)

    投稿命中率:25.0
    经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2011-10-18 匿名用户

    帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2018-04-21 showen

    3月22号投稿
    4月10号大修
    4月21日修改完再次投稿
    当日接收,效率最快的一次投稿

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2020-03-26 钱湖鑫

    亲,最后咋样了?188****8186(暂无匿称) 2019-04-14 00:08:00 发表:
    投稿1周内就送外审了UnderReview中希望顺利接受

    188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2020-01-16 @MD & PhD@

    cas升级版分区绿皮是一区top了。。。我喜欢。。。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2019-11-13 @MD & PhD@

    绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了188****8186(暂无匿称) 2019-11-01 00:00:00 发表:
    Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?

    188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2019-11-01 1dd96cb3m86(暂无匿称)

    Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?188****8186(暂无匿称) 2019-09-28 00:00:00 发表:
    我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天

    188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2019-09-28 1dd96cb3m86(暂无匿称)

    我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天LLL123456789 2018-09-03 10:57:00 发表:
    with editor 1个月,啥情况啊

    LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2018-09-03 LLL123456789

    with editor 1个月,啥情况啊

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1053582, encodeId=dde41053582a7, content=投稿命中率:25.0<br>经验分享:撰写肿瘤分期,第三天显示under review,希望能顺利外审!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Tue Sep 21 21:56:26 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484932, encodeId=ff1f48493240, content=帮别人写了1篇,半年发表,自己投了1篇,半年才给个回复,莫名其妙!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Oct 18 16:29:00 CST 2011, time=2011-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555242, encodeId=bcfe5552426c, content=3月22号投稿 <br> 4月10号大修 <br> 4月21日修改完再次投稿 <br> 当日接收,效率最快的一次投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=464, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02681608493, createdName=showen, createdTime=Sat Apr 21 19:05:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587456, encodeId=7fe358e456a1, content=亲,最后咋样了?<span class="quote">188****8186(暂无匿称) 2019-04-14 00:08:00 发表:<br>投稿1周内就送外审了UnderReview中希望顺利接受</span>, beContent=188****8186(暂无匿称) 2019-04-14 00:08:00 发表: 投稿1周内就送外审了UnderReview中希望顺利接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLvdkH0jmPBljZUbZvdObtFEh4XFq0Or5JXGXMx5S9qHU3r6ZnlicJiaMNqnFp5hVdnCMmnh9eC4R8Q/132, createdBy=746b5197351, createdName=钱湖鑫, createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583438, encodeId=667b583438bc, content=cas升级版分区绿皮是一区top了。。。我喜欢。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Thu Jan 16 00:00:00 CST 2020, time=2020-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579812, encodeId=58565e9812b4, content=绿皮好像换了主编,要开始拉if了?elsevier旗下的许多杂志if都开始猛涨了<span class="quote">188****8186(暂无匿称) 2019-11-01 00:00:00 发表:<br>Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?</span>, beContent=188****8186(暂无匿称) 2019-11-01 00:00:00 发表: Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/c1cc6c482d21459da935cfac488063b2/6e9e12c2bcaa465a9230f699381f6e1d.jpg, createdBy=f0911736061, createdName=@MD & PhD@, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579154, encodeId=2c4c5e915402, content=Your manuscript has been reviewed by the Editors of the journal. Overall, it did not receive a high enough priority score for publication in the journal and will not proceed to peer-review. We currently have a very high number of excellent submissions and can publish only the very best papers. For further information please refer to our editorials:? "What next" (Radiother. Oncol. 2014 Jan; 110 (1): 1-2, ?https://www.sciencedirect.com/science/article/pii/S0167814014000450).? "Continuously getting a bit more picky…" (Radiother. Oncol. 2019 Jan; 130: 1,?https://www.sciencedirect.com/science/article/pii/S0167814018336491)? Thank you for giving us the opportunity to consider your work for publication in Radiotherapy & Oncology. ?Although your submission was not successful on this occasion, we hope that you will consider the journal for future work of relevance and importance to radiation oncology.?<span class="quote">188****8186(暂无匿称) 2019-09-28 00:00:00 发表:<br>我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天</span>, beContent=188****8186(暂无匿称) 2019-09-28 00:00:00 发表: 我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577044, encodeId=07675e7044b7, content=我最近也with editor20+天,你那篇最后怎么样?和我以前的投稿不一样,以前7-10天<span class="quote">LLL123456789 2018-09-03 10:57:00 发表:<br>with editor 1个月,啥情况啊</span>, beContent=LLL123456789 2018-09-03 10:57:00 发表: with editor 1个月,啥情况啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 28 00:00:00 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560670, encodeId=fc4e5606e048, content=with editor 1个月,啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:57:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560669, encodeId=03f25606691a, content=with editor 1个月,瑟瑟发抖....., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4def2361633, createdName=LLL123456789, createdTime=Mon Sep 03 10:56:00 CST 2018, time=2018-09-03, status=1, ipAttribution=)]
    2018-09-03 LLL123456789

    with editor 1个月,瑟瑟发抖.....

    0

共68条页码: 2/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分